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response in part II and III (p = 0.0078 and p = 0.0072, respectively). a trend to better 
results for the LCE group was observed in part I and IV. CONCLUSIONS: Levodopa/
carbidopa/entacapone shows a signiﬁ cant better patient and physician global percep-
tion in the LCE treatment group vs. LC group in PD patients with early WO and 
ADLs deterioration.
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OBJECTIVES: Since its development in the 80’s, variations of the Alzheimer’s Disease 
Assessment Scale-Cognitive subscale (ADAS-Cog), a Clinician-Reported Outcome 
(ClinRO) measure, have been used to monitor disease progression and treatment 
efﬁ cacy in Alzheimer’s disease. The objective of this study was to identify all versions 
used as a basis for translation in Mapi Institute projects and to take stock of existing 
translations. METHODS: The review was based on all ADAS-Cog translation projects 
performed by Mapi Institute. RESULTS: Sixteen projects were identiﬁ ed representing 
a total of 70 languages and 219 translations. Translations were based on 11 source 
versions which differed in terms of content (number of items, order of items and 
instructions), and format. The number of items ranged from 11 to 15. Four studies 
used 13 items, but only in two cases the same items were used although in a different 
order. Four studies used 12 items: only two studies used the same items (with a dif-
ferent list of words for the Word Recognition Task), but again in a different order. 
Format and instructions differed in all cases. In most projects the source version 
provided by the sponsor was a single document mixing instructions with the rater and 
response forms. Only in 3 cases the original consisted in a separate instruction manual 
and response forms. With regard to available translations, more than one translation 
was identiﬁ ed in 56 of the 70 available languages and in one language (Swedish) as 
many as 7 translations. CONCLUSIONS: The abundance of different versions of the 
same questionnaire both in its original US English form as in translations makes 
comparisons between studies or pooling of data difﬁ cult for both researchers and 
users. In the light of FDA’s recent PRO guidance it would be beneﬁ cial to demand 
the same scientiﬁ c rigor when using ClinROs in international studies.
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OBJECTIVES: Quality of life (QoL) is an important measure that is often overlooked 
in the assessment of multiple sclerosis (MS). The MS International QoL (MusiQoL) 
questionnaire is a validated, MS-speciﬁ c instrument. This study aimed to assess the 
responsiveness of the MusiQoL questionnaire to changes in Expanded Disability 
Status Scale (EDSS) scores in patients with MS. METHODS: In this ongoing, 
24-month, multicentre, observational study, MusiQoL and EDSS scores were recorded 
at baseline (BL) and at 6-month intervals. The primary endpoint is change in MusiQoL 
index score from BL to month 24 (including effect size). Secondary endpoints include 
change in MusiQoL index score from BL to month 12 and change in MusiQoL scale 
scores. RESULTS: Of 600 patients enrolled, 474 had evaluable BL and month-12 
EDSS and MusiQoL index data. At BL, mean (SD) EDSS score was 2.9 (1.9); mean 
(SD) MusiQoL index score was 68.5 (14.4); and mean (SD) MusiQoL scale scores 
ranged from 59.9 (24.8) to 85.4 (18.5). At month 12, 68 patients (14.3%) had a worse 
EDSS score than that recorded at BL. Mean (SD) change in MusiQoL index score was 
0.48 (10.99) overall, and −1.00 (9.88) in “worsened” patients; effect sizes were 0.03 
and −0.08, respectively. Changes from BL to month 12 in MusiQoL scale scores were 
mostly small. However, there were larger (mean [SD]) decreases in some subscales at 
month 12 for “worsened” patients: “Activities-of-daily-living” (−4.20 [18.07]); “Rela-
tionship-with-family” (−5.14 [23.43]); ‘Sentimental-and-sexual-life’ (−4.11 [17.56]); 
and ‘Relationship-with-health care-system’ (−3.56 [14.11]). Effect sizes were −0.17, 
−0.25, −0.14 and −0.21 respectively. Conversely, the mean (SD) change in ‘Symptoms’ 
score was 5.36 (17.27) at month 12 for ‘worsened’ patients (effect size: 0.24). CON-
CLUSIONS: As expected, most MusiQoL scores decreased over 12 months in patients 
with worsening EDSS scores, indicating poorer QoL and conﬁ rming the utility of the 
MS-speciﬁ c MusiQoL in rating QoL.
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OBJECTIVES: Huntington’s disease (HD) is a rare neurodegenerative disease leading 
to sustained disability for patients and poor quality of life (QoL) for patients as well 
as caregivers. This study investigated the impact of HD on caregivers’ QoL and its 
drivers. METHODS: The European HD burden study (Euro-HDB) is an ongoing 
cross-sectional survey among HR patients and their caregivers in six countries (France, 
Italy, Germany, UK, Sweden and Spain). The Huntington’s disease Quality of Life 
Battery for Carers (HDQoL-C) short-version, a previously validated questionnaire by 
Aubeeluck A. and Buchanan H., was administered. Pearson correlations with generic 
HR-QOL (SF36, EQ5D) and the speciﬁ c HR-QOL in HD for patients (HQOLI) were 
evaluated. The determinants of caregiver QOL among drivers among patients’ clinical 
characteristics (voluntary movement disorders, chorea, depression/anxiety, psychotic 
disorder, cognition, temper) were studied by regression analysis adjusting on age, sex 
and occupational categories. The relationship between QOL of patients and caregivers 
were also explored. RESULTS: To date, 201 caregivers in France and 124 in Italy 
have been enrolled. For France (respectively Italy) 6% (12%) were completely unsatis-
ﬁ ed by their overall QOL and 7% (5%) were totally satisﬁ ed. HDQoL-C scores were 
poorly correlated with generic caregiver HR-QOL: correlation equaled 0.31 for EQ5D 
utility and varied between 0.04 and 0.45 for the eight domains of SF36. Correlation 
was quite high (0.59; P < 0.01) between HDQoL-C and HQOLI. Drivers of caregiver’s 
QoL were voluntary movement disorders (p = 0.049), depression/anxiety (p = 0.02), 
psychotic disorder (p = 0.01) and cognition (p = 0.01). Temper and chorea were not 
drivers of caregivers’ QOL independently of other clinical characteristics. CONCLU-
SIONS: Caregivers QOL worsens as the patient clinical characteristics deteriorate 
especially voluntary movement disorders, depression/anxiety, psychotic disorders and 
cognition disorders. Patients and caregiver QoL was indirectly correlated via patient 
clinical scores. The potential impact on caregiver QOL should be considered in evalu-
ations of innovative HD treatments.
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OBJECTIVES: This study assesses, for an estimated EU pain population of 50 million 
patients, the impact of pain severity and frequency on three dimensions of health 
related quality of life (HRQoL): the SF-12 MCS and PCS scores and (ii) the SF-6D 
absolute utility scores. METHODS: The study is based on data from the internet based 
2008 National Health and Wellness Survey undertaken in the UK, France, Spain, 
Germany and Italy. This study identiﬁ ed 11,000 respondents (1 in 5 of the estimated 
big 5 EU countries) who had experienced pain in the last month. The assessment of 
the quantitative impact of pain status on HRQoL is estimated via three single equation 
generalized linear (ordinary least squares) models which estimate the impact of pain 
on PCS, MCS and utility scores. The model includes a range of variables which have 
been shown in previous population studies to impact HRQoL. These include: socio-
demographic factors, health risk behaviors, comorbidity status, medication utilization, 
duration of medication utilization and satisfaction with care. The experience of pain 
is captured by a combination of severity and frequency categorical variables. 
RESULTS: Pain has a substantial impact on all three of the dimensions of HRQoL 
considered here. Compared to the reference category (mild pain experienced weekly 
or less) the presence of severe, daily pain has a substantial impact on SF-12 PCS scores 
(−13.85 points); SF-12 MCS scores (−4.72); and SF-6D utilities (−0.147). There is a 
marked gradient on scores by severity and frequency of pain experience. The impact 
of pain on HRQoL is more signiﬁ cant than the impact of socio-demographic charac-
teristics, health risk factors, comorbidities and the experience of pain medication. 
CONCLUSIONS: The presence of moderate and severe pain imposes a signiﬁ cant 
burden on persons reporting pain in the big 5 EU countries; the burden increases the 
greater the frequency and severity.
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OBJECTIVES: The aim of the study was to survey some objective and subjective 
indicators determining the quality of life of people with Down’s syndrome (DS), born 
between 1975 and 2005, looked after in their families in the Southern-Transdanubian 
region of Hungary. The relationship between the parental level of education and the 
above factors was explored. METHODS: On the basis of the VRONY database 
(National Registry of Congenital Anomalies) health visitors contacted families looking 
after DS people (N = 107), and conducted anonymous, questionnaire surveys in 
2008–2009. Reading was examined from school-age (N = 79), drawing and writing 
was examined depending on age. RESULTS: The abilities under examination moved 
